sulfur has been researched along with Carcinoma 256, Walker in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kotzerke, J; Luboldt, W; Matzky, C; Pinkert, J; Wunderlich, G | 1 |
| Basinger, MA; Holscher, MA; Jones, MM | 1 |
| Davis, W; Ross, WC | 1 |
3 other study(ies) available for sulfur and Carcinoma 256, Walker
| Article | Year |
|---|---|
Radiopharmaceutical tracking of particles injected into tumors: a model to study clearance kinetics.
Topics: Animals; Carcinoma 256, Walker; Epinephrine; Female; Humans; Injections, Intralesional; Kidney; Liver; Lung; Microspheres; Models, Animal; Neoplasms; Radioisotopes; Radiopharmaceuticals; Rats; Rats, Wistar; Rhenium; Sarcoma, Yoshida; Serum Albumin; Spleen; Sulfur; Tissue Distribution | 2009 |
Relative effectiveness of some compounds for the control of cisplatin-induced nephrotoxicity.
Topics: Animals; Carcinoma 256, Walker; Cisplatin; Drug Administration Schedule; Female; Kidney Diseases; Leukemia L1210; Mice; Mice, Inbred DBA; Platinum; Rats; Rats, Inbred Strains; Sulfur | 1991 |
A highly reactive sulfur mustard gas derivative for localized infusion studies.
Topics: Alkylating Agents; Animals; Carcinoma 256, Walker; Injections, Intra-Arterial; Injections, Intravenous; Mustard Compounds; Rats; Sulfur | 1965 |